Literature DB >> 10820276

Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation.

H Nagase1, M Miyamasu, M Yamaguchi, T Fujisawa, K Ohta, K Yamamoto, Y Morita, K Hirai.   

Abstract

We examined the expression of transcripts of a panel of chemokine receptors in human eosinophils and found intense constitutive expression of CXCR4 mRNA. Although surface CXCR4 protein was hardly detectable in the peripheral blood or freshly isolated eosinophils, surface expression of CXCR4 became gradually apparent during incubation at 37 degrees C. In contrast, the level of CCR3 expression was virtually unchanged during the incubation. Stromal cell-derived factor-1alpha (SDF-1alpha), the natural ligand of CXCR4, elicited an apparent Ca2+ influx in these cells and induced a strong migratory response comparable to that by eotaxin. The surface expression of CXCR4 in eosinophils was up-regulated by IFN-gamma, TNF-alpha, and TGF-beta while it was down-regulated by IL-4 and eosinophil-directed hemopoietins such as IL-5. The CXCR4 expression did not always parallel the apoptotic changes in cytokine-treated eosinophils. In contrast to IL-4 and IFN-gamma, IL-5 potently reduced the level of CXCR4 mRNA. It seems unlikely that CXCR4 is fundamentally involved in the pathogenesis of allergic disorders by inducing the migration of eosinophils toward inflammatory sites, because a Th2-dominant state down-regulates eosinophil CXCR4 expression. However, CXCR4 may affect the size of the mobilizable pool by holding eosinophils at noninflamed tissues. Th2-dominant state may favor the liberation of eosinophils by down-regulating CXCR4 expression. The interplay between CXCR4 and SDF-1alpha in eosinophils potentially plays an important role in the accumulation of these cells at the allergic inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820276     DOI: 10.4049/jimmunol.164.11.5935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

2.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

3.  Eosinophils are required for the maintenance of plasma cells in the bone marrow.

Authors:  Van Trung Chu; Anja Fröhlich; Gudrun Steinhauser; Tobias Scheel; Toralf Roch; Simon Fillatreau; James J Lee; Max Löhning; Claudia Berek
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

4.  Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells.

Authors:  Xiao-ping Zhao; Yong-yao Huang; Yu Huang; Ping Lei; Ji-lin Peng; Sha Wu; Min Wang; Wen-han Li; Hui-fen Zhu; Guan-xin Shen
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

5.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

Authors:  Nicholas W Lukacs; Aaron Berlin; Dominique Schols; Renato T Skerlj; Gary J Bridger
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model.

Authors:  Jianguo Xu; Edilson Torres; Ana L Mora; Hyunsuk Shim; Allan Ramirez; David Neujahr; Kenneth L Brigham; Mauricio Rojas
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

7.  SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.

Authors:  Feng Pan; Shijie Ma; Weike Cao; Haining Liu; Fengli Chen; Xiaofei Chen; Ruihua Shi
Journal:  Mol Biol Rep       Date:  2013-05-28       Impact factor: 2.316

8.  Highly up-regulated CXCR3 expression on eosinophils in mice infected with Schistosoma japonicum.

Authors:  He Li; Hu Chunsong; Cai Guobin; Zhang Qiuping; Li Qun; Zhang Xiaolian; Huang Baojun; Zhang Linjie; Liu Junyan; Jiang Mingshen; Tan Jinquan
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2.

Authors:  Huilong Chen; Xiangqin Xu; Jieming Teng; Sheng Cheng; Hansvin Bunjhoo; Yong Cao; Jin Liu; Jungang Xie; Congyi Wang; Yongjian Xu; Weining Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.

Authors:  Jeong Sup Song; Chun Mi Kang; Hyeon Hui Kang; Hyung Kyu Yoon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.